Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia Email: m.flood@latrobe.edu.au Background: Primary postpartum haemorrhage (PPH) is a leading cause of maternal morbidity with potential negative impacts on breastfeeding (BF). BF has many benefits for mother and baby. The Victorian Perinatal Data Collection (VPDC) collects data for each birth in Victoria including for PPH. Since 2009, PPH has been derived from reported estimated blood loss (EBL). 'BF initiated' and 'Exclusive BF at last feed before discharge' were also collected.
Aim: To determine the influence of PPH and severe PPH on initiation of BF and exclusive BF at discharge from the birth hospital for term liveborn singleton births in Victoria for 2009-13.
Methods: Population-based retrospective cross-sectional study on VPDC data for all eligible confinements (n=364,706) for 2009-13. Cases with missing data were excluded (n=5,897). EBL was categorised as PPH ≥500 mL and severe PPH ≥1500 mL. Descriptive analysis and Chi-square analysis for statistical significance were undertaken.
Results: Initiation of BF did not differ between women who did and did not experience a PPH (95.0% The Neonatal Nurse Practitioner (NNP) role originated in the 1970's in the United States from a short fall in physician's. This occurred because of changes in medical training which reduced time in specialist areas and in conjunction, the demand for neonatal care increased due to the survival of premature babies and advances in specialised care. This was mirrored in Australia thirty-years later however, there are still wide discrepancies between roles and responsibilities. The aim of this review is to identify the challenges that NNP face and explore possible role development opportunities to make the position sustainable.
Methods: Current review of the literature (MESH TERMSneonatal and/or nurse practitioner, Australia) revealed fourteen published articles and government documents identified requirements for endorsement and standards for nurse practitioner practice.
Results: Neonatal nurse practitioners spend most of their time delivering direct patient care regardless of the clinical setting, however elements of research, education and leadership are still incorporated within clinical practice. Alongside the clinical role, antenatal counselling, facilitation of communication amongst the multidisciplinary team and parents, prescribing, ordering diagnostic tests have all became core components to define the scope of the NNP. However, as the role has expanded NNP must adapt to changes to continue to be recognised as a valuable member of the multidisciplinary team especially as registered nurses start to take on extended roles.
Conclusions: The senior clinical role of the NNP continues to evolve. There are challenges to be overcome, however there are now more than thirty NNPs in Australia and together the possibilities for expansion of their role are limitless. This can only be of benefit to our babies, their families and the nursing profession. Background: There is currently no international consensus on the optimal management of neonatal hyperglycaemia in premature neonates. The aim of this study was to identify areas of variability in the clinical management of neonatal hyperglycaemia in neonatal intensive care units (NICUs) in Australia and New Zealand.
Methods: Treatment protocols for tertiary NICUs in Australia and New Zealand were retrieved and analysed. Protocols were compared and contrasted.
Results: Treatment protocols for 25 out of 29 Australasian NICUs were available for analysis. In 52% of protocols, treatment was indicated when a random blood glucose level (BGL) was above 10 -15 mmol/L. The first-line treatment option was intravenous infusion of insulin in 52% of NICUs, whereas 36% recommended a reduction in glucose-containing infusions. An insulin dose range of 0.01 -0.1 units/kg/hour was recommended in 64% of protocols. Only 24% of protocols reported a method for insulin dose titration and 60% of protocols reported a BGL monitoring frequency.
Conclusions: Most NICUs have protocols for how to manage neonatal hyperglycaemia, but the level of detail is variable. This analysis shows considerable differences in clinical practice which likely reflect the lack of published consensus on the optimal management of this condition. (mmol/L), Creatinine(μmol/L) and AG was 128(9), 23.3(2.4), 55(9) and 14(2.5) respectively. A logistic regression was performed to ascertain the effects on the likelihood of hospitalization. The logistic regression model was statistically significant, χ 2 (4) = 24.1 p<0.0001. The model explained 34.0% (Nagelkerke R 2 ) of the variance in hospitalization. Only AG independently predicted the odds of hospitalization (β=0.465;SE=0.15;P=0.001). Each unit increase in AG increased the odds of hospitalization by 1.6 times. The ROC AUC of AG for predicting hospitalization was 0.8, with AG>15 having 82% sensitivity and 79% specificity in predicting hospitalization. Medical School, University of Auckland, New Zealand Email: kgat447@aucklanduni.ac.nz Background: Bi-national clinical practice guidelines recommend the use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth (<30 weeks gestation). The aims of this study were to assess current use of magnesium sulphate, to determine if use has changed since the bi-national survey in 2012, and to evaluate the enablers and barriers to use.
ADMISSION HIGH ANION GAP IS ASSOCIATED WITH INCREASED ODDS OF HOSPITALIZATION IN OBSTETRIC PATIENTS PRESENTING WITH
Methods: A SurveyMonkey questionnaire was sent to lead health professionals at 26 tertiary maternity hospitals in Australia and New Zealand. The survey asked at what gestational ages magnesium sulphate is given, any perceived barriers to use and if use was audited. Data were analysed using descriptive statistics with p<0.05 being significant.
Results: The median use of antenatal magnesium sulphate when indicated was reported as 90% (IQR 80-90%). The uptake of the use of magnesium sulphate for fetal neuroprotection has increased from 80% (IQR 53-90%) in the last survey. All respondents reported that the majority of health professionals at their hospital would use magnesium sulphate at <30 weeks gestation. The top three enablers for use were reported as information sheets for health professionals, PowerPoint presentations and posters. The main reasons why eligible women did not receive antenatal magnesium sulphate were imminent birth, being short staffed and patient declined. Use of antenatal magnesium sulphate has been audited in 47% of the hospitals.
Conclusions: Uptake in the use of magnesium sulphate for fetal neuroprotection has increased since the last survey in 2012. Barriers to the use of magnesium sulphate identified have institutional and consumer implications. 
THE EFFECT OF CORD CLAMPING ON HEART RATE IN INFANTS IMMEDIATELY AFTER BIRTH

